RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
U.S. FDA Drug Approvals for Breast Cancer — A Decade in Review | Clinical Cancer Research https://t.co/wuF7ocL5HV
RT @RitaNandaMD: We’ve made great progress, but there is much left to be done. Can’t wait to see what the next decade will hold in our ques…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @RitaNandaMD: We’ve made great progress, but there is much left to be done. Can’t wait to see what the next decade will hold in our ques…
RT @RitaNandaMD: We’ve made great progress, but there is much left to be done. Can’t wait to see what the next decade will hold in our ques…
RT @RitaNandaMD: We’ve made great progress, but there is much left to be done. Can’t wait to see what the next decade will hold in our ques…
We’ve made great progress, but there is much left to be done. Can’t wait to see what the next decade will hold in our quest for precision medicine. #bcsm https://t.co/wqVFV5ozKC
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @DraAnaCasas: Treatment of BC patients greatly impacted by 30 FDA approvals of multiple drugs/indications into decade 2010-2020: 23 regu…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @DraAnaCasas: Treatment of BC patients greatly impacted by 30 FDA approvals of multiple drugs/indications into decade 2010-2020: 23 regu…
RT @Stickit2Stage4: Over the last 10yrs #research paved the way for the @FDA to grant new treatments for twenty-six approvals in metastatic…
RT @DraAnaCasas: Treatment of BC patients greatly impacted by 30 FDA approvals of multiple drugs/indications into decade 2010-2020: 23 regu…
U.S. FDA Drug Approvals for Breast Cancer — A Decade in Review https://t.co/X0lFSIlD62
RT @DraAnaCasas: Treatment of BC patients greatly impacted by 30 FDA approvals of multiple drugs/indications into decade 2010-2020: 23 regu…
RT @DraAnaCasas: Treatment of BC patients greatly impacted by 30 FDA approvals of multiple drugs/indications into decade 2010-2020: 23 regu…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @tmprowell: Summarizing a decade of progress in #breastcancer for #OncTwitter & patient #advocacy colleagues! #bcsm
Summary of a decade of #research and breakthroughs for #breastcancer treatment. Work continues to improve #cancerequity in #trials. #bcsm #FDA #OncTwitter #brca
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @DraAnaCasas: Treatment of BC patients greatly impacted by 30 FDA approvals of multiple drugs/indications into decade 2010-2020: 23 regu…
RT @DraAnaCasas: Treatment of BC patients greatly impacted by 30 FDA approvals of multiple drugs/indications into decade 2010-2020: 23 regu…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
Treatment of BC patients greatly impacted by 30 FDA approvals of multiple drugs/indications into decade 2010-2020: 23 regular and 7 accelerated approval. 26 MBC ( PFS 22 ) & 4 EBC (ORR 1) @_SOLTI @GEICAM @_SEOM @OncoAlert https://t.co/jg4yBKs
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @tmprowell: Summarizing a decade of progress in #breastcancer for #OncTwitter & patient #advocacy colleagues! #bcsm
RT @Stickit2Stage4: Over the last 10yrs #research paved the way for the @FDA to grant new treatments for twenty-six approvals in metastatic…
RT @tmprowell: Summarizing a decade of progress in #breastcancer for #OncTwitter & patient #advocacy colleagues! #bcsm
Summarizing a decade of progress in #breastcancer for #OncTwitter & patient #advocacy colleagues! #bcsm
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpoints, and regulatory considerations - via @CCR_AACR. Important article by our breast cancer team in Division of Oncology 1! https://t.
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
U.S. FDA Drug Approvals for Breast Cancer — A Decade in Review https://t.co/jCjjKffCvg
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @BianchiniGP: Great overview of a decade of achievements in breast cancer research leading to 30 new indications approved by FDA. Impres…
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @BianchiniGP: Great overview of a decade of achievements in breast cancer research leading to 30 new indications approved by FDA. Impres…
RT @BianchiniGP: Great overview of a decade of achievements in breast cancer research leading to 30 new indications approved by FDA. Impres…
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @BianchiniGP: Great overview of a decade of achievements in breast cancer research leading to 30 new indications approved by FDA. Impres…
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @DrSujanaENT: For our @ShesOnCall family - read this 👇🏽 and watch this 👉🏽 https://t.co/9nveiHOYQS about #breastcancer . @MegKinnardAP @a…
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @DrGattiMays: 👏👏👏 A great review on pivotal approvals in #breastcancer #bcsm - incredible work by our talented #FDA colleges @SuparnaWed…
RT @ErikaHamilton9: Fantastic summary of the #bcsm approvals in the past decade. Hint: there are a lot!!!
RT @DrGattiMays: 👏👏👏 A great review on pivotal approvals in #breastcancer #bcsm - incredible work by our talented #FDA colleges @SuparnaWed…
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
30 drug approvals in breast cancer over the past 10 yrs. - 23 regular approvals; 7 accelerated - 26 in metastatic disease; 4 in non-metastatic - only 3 approvals based on ORR; majority were PFS (or iDFS in adjuvant). #bcsm
RT @BianchiniGP: Great overview of a decade of achievements in breast cancer research leading to 30 new indications approved by FDA. Impres…
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @FDAOncology: Read about FDA approvals from 2010-2020 for the treatment of breast malignancies and their relevant clinical trials, endpo…
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz
RT @PTarantinoMD: What a decade, for breast oncology https://t.co/NStFUmzGmz